Status:
UNKNOWN
Exploration of Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop Recorders
Lead Sponsor:
Marianna Fontana
Conditions:
Arrythmia
Cardiac Amyloidosis
Eligibility:
All Genders
18+ years
Brief Summary
The overall aim of this study is to improve our understanding of the effects of the build-up of amyloid deposits in the heart, in particular, our understanding of the risk of abnormal heart beats, or ...
Detailed Description
Sudden cardiac death (SCD) occurs in up to 1/3 of patients with AL amyloidosis within the first 90 days but conflicting findings have been reported on the mechanism. Electromechanical dissociation (EM...
Eligibility Criteria
Inclusion
- Age over 18 years
- Diagnosed with cardiac AL amyloidosis using standard diagnostic techniques and criteria at the NAC
- Willing and able to provide written informed consent
Exclusion
- Patient who already have a cardiac device inserted, such as a permanent pacemaker (PPM), implantable cardioverter-defibrillator (ICD) or implantable cardiac monitor (ILR)
- Other pre-existing cardiac or other pathology which, in the investigators opinion, would adverse affect primary outcome data collection
- Contraindication to CMR imaging
Key Trial Info
Start Date :
May 27 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04856267
Start Date
May 27 2021
End Date
May 1 2023
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Free London NHS Foundation Trust
London, United Kingdom, NW3 2QG